British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable






